CardiaMend™
Introducing the first in a range of products based upon the f-EBM technology in the field of cardiac repair and regeneration.
CardiaMend™ Pericardial and Epicardial Reconstruction Matrix
Cardiamend™ is an FDA cleared device indicated for pericardial repair and reconstruction and epicardial support and repair. Combining strength and the ability to be remodeled into native tissue, CardiaMend™ offers cardiac surgeons an ideal biomaterial for pericardial and epicardial reconstruction procedures as an adjunct to coronary artery bypass graft (CABG) or valvular surgery.
Preclinical studies in large animal models have shown that CardiaMend™ not only repairs pericardial and epicardial defects with no scarring or surrounding tissue adhesions, but is also remodeled into tissue resembling native cardiac tissue.
Pericardial repair in a large animal model
A 3-month study in a large animal model exhibiting both pericardial and epicardial defects that had been repaired with CardiaMend™ showed:
No scarring or inflammation associated with CardiaMend™
Pericardial repair showed no adhesions onto the epicardium
Remodeling of CardiaMend™ into native tissue
Neo-vascularization within remodeled tissue showing excellent tissue viability
With the upcoming introduction of CardiaMend™, Helios Cardio will provide cardiac surgeons with a unique biomaterial combining mechanical strength and a long history of clinical safety, together with ideal characteristics for cardiac tissue regeneration.
Clinical Research
Helios Cardio is developing novel cell and pharmaco- therapies in combination with CardiaMend™. We are seeking to collaborate with innovative cardiac surgeons to bring these innovations into the clinic. Please contact us for further information.